Invesco Nasdaq Biotechnology Etf Performance

IBBQ Etf  USD 21.59  0.20  0.92%   
The etf retains a Market Volatility (i.e., Beta) of 0.8, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Invesco Nasdaq's returns are expected to increase less than the market. However, during the bear market, the loss of holding Invesco Nasdaq is expected to be smaller as well.

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Invesco Nasdaq Biotechnology are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental drivers, Invesco Nasdaq is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors. ...more
JavaScript chart by amCharts 3.21.151232025FebMar -4-202468
JavaScript chart by amCharts 3.21.15Invesco Nasdaq Biote Invesco Nasdaq Biote Dividend Benchmark Dow Jones Industrial
1
Invesco Nasdaq Biotechnology ETF Sees Significant Increase in Short Interest
01/31/2025
2
Proactive Strategies - Stock Traders Daily
02/27/2025
3
Invesco Nasdaq Biotechnology ETF Declares Dividend of 0.04
03/24/2025
In Threey Sharp Ratio0.11
  

Invesco Nasdaq Relative Risk vs. Return Landscape

If you would invest  2,136  in Invesco Nasdaq Biotechnology on December 30, 2024 and sell it today you would earn a total of  23.00  from holding Invesco Nasdaq Biotechnology or generate 1.08% return on investment over 90 days. Invesco Nasdaq Biotechnology is currently generating 0.0235% in daily expected returns and assumes 1.1289% risk (volatility on return distribution) over the 90 days horizon. In different words, 10% of etfs are less volatile than Invesco, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
JavaScript chart by amCharts 3.21.15CashMarketIBBQ 0.00.20.40.60.81.01.2 -0.04-0.03-0.02-0.010.000.010.02
       Risk  
Given the investment horizon of 90 days Invesco Nasdaq is expected to generate 1.31 times more return on investment than the market. However, the company is 1.31 times more volatile than its market benchmark. It trades about 0.02 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

Invesco Nasdaq Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Invesco Nasdaq's investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as Invesco Nasdaq Biotechnology, and traders can use it to determine the average amount a Invesco Nasdaq's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0209

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIBBQ

Estimated Market Risk

 1.13
  actual daily
10
90% of assets are more volatile

Expected Return

 0.02
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.02
  actual daily
1
99% of assets perform better
Based on monthly moving average Invesco Nasdaq is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Invesco Nasdaq by adding it to a well-diversified portfolio.

Invesco Nasdaq Fundamentals Growth

Invesco Etf prices reflect investors' perceptions of the future prospects and financial health of Invesco Nasdaq, and Invesco Nasdaq fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Invesco Etf performance.

About Invesco Nasdaq Performance

Assessing Invesco Nasdaq's fundamental ratios provides investors with valuable insights into Invesco Nasdaq's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Invesco Nasdaq is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
The fund generally will invest at least 90 percent of its total assets in the securities that comprise the index. Invesco Nasdaq is traded on NASDAQ Exchange in the United States.
Latest headline from thelincolnianonline.com: Invesco Nasdaq Biotechnology ETF Declares Dividend of 0.04
The fund retains 99.97% of its assets under management (AUM) in equities
When determining whether Invesco Nasdaq Biote is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Invesco Etf is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Invesco Nasdaq Biotechnology Etf. Highlighted below are key reports to facilitate an investment decision about Invesco Nasdaq Biotechnology Etf:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Invesco Nasdaq Biotechnology. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
The market value of Invesco Nasdaq Biote is measured differently than its book value, which is the value of Invesco that is recorded on the company's balance sheet. Investors also form their own opinion of Invesco Nasdaq's value that differs from its market value or its book value, called intrinsic value, which is Invesco Nasdaq's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Invesco Nasdaq's market value can be influenced by many factors that don't directly affect Invesco Nasdaq's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Invesco Nasdaq's value and its price as these two are different measures arrived at by different means. Investors typically determine if Invesco Nasdaq is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Invesco Nasdaq's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Discover investing ideas

Utilize additional investing modules